ES2168314T3 - Anticuerpos monoclonales contra las celulas espumosas humanas y sus utilizaciones farmaceuticas y diagnosticas. - Google Patents

Anticuerpos monoclonales contra las celulas espumosas humanas y sus utilizaciones farmaceuticas y diagnosticas.

Info

Publication number
ES2168314T3
ES2168314T3 ES94930226T ES94930226T ES2168314T3 ES 2168314 T3 ES2168314 T3 ES 2168314T3 ES 94930226 T ES94930226 T ES 94930226T ES 94930226 T ES94930226 T ES 94930226T ES 2168314 T3 ES2168314 T3 ES 2168314T3
Authority
ES
Spain
Prior art keywords
foam cells
pharmaceutical
monoclonal antibodies
antibodies against
against human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94930226T
Other languages
English (en)
Inventor
Smet Walter De
Ann Union
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujirebio Europe NV SA
Original Assignee
Innogenetics NV SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innogenetics NV SA filed Critical Innogenetics NV SA
Application granted granted Critical
Publication of ES2168314T3 publication Critical patent/ES2168314T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0645—Macrophages, e.g. Kuepfer cells in the liver; Monocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/385—Hormones with nuclear receptors of the family of the retinoic acid recptor, e.g. RAR, RXR; Peroxisome proliferator-activated receptor [PPAR]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809—Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA INVENCION SE REFIERE A CELULAS DE ESPUMA HUMANAS GENERADAS "IN VITRO" A PARTIR DE LINEAS CELULARES RELACIONADAS CON MONOCITOS/MACROFAGOS QUE EFECTUAN UNA ELEVACION DE LA CANTIDAD MEDIA DE COLESTEROL INTRACELULAR DE AL MENOS 139+36 {MI}G/MG DE PROTEINA CELULAR SEGUN SE DETERMINA POR HPLC, ESTANDO CARACTERIZADO EL COLESTEROL POR UN GRADO DE ENTRE 46+6% DE ESTERIFICACION SEGUN SE DETERMINA POR HPLC. LA INVENCION TAMBIEN SE REFIERE A ANTICUERPOS MONOCLONALES SELECCIONADOS A PARTIR DE LAS CELULAS DE ESPUMA Y QUE PUEDEN UTILIZARSE PARA PROPOSITOS FARMACEUTICOS Y DE DIAGNOSTICO.
ES94930226T 1993-11-02 1994-10-26 Anticuerpos monoclonales contra las celulas espumosas humanas y sus utilizaciones farmaceuticas y diagnosticas. Expired - Lifetime ES2168314T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93402691 1993-11-02

Publications (1)

Publication Number Publication Date
ES2168314T3 true ES2168314T3 (es) 2002-06-16

Family

ID=8214763

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94930226T Expired - Lifetime ES2168314T3 (es) 1993-11-02 1994-10-26 Anticuerpos monoclonales contra las celulas espumosas humanas y sus utilizaciones farmaceuticas y diagnosticas.

Country Status (10)

Country Link
US (1) US6027922A (es)
EP (2) EP1188824A3 (es)
AT (1) ATE211167T1 (es)
AU (1) AU7940594A (es)
DE (1) DE69429534T2 (es)
DK (1) DK0726942T3 (es)
ES (1) ES2168314T3 (es)
HK (1) HK1042726A1 (es)
PT (1) PT726942E (es)
WO (1) WO1995012666A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1474685A2 (de) * 2002-02-12 2004-11-10 Biotesys Gmbh Analyse von vitalstoffen
WO2006051551A2 (en) * 2004-11-15 2006-05-18 Quantomix Ltd. Device and method for analysis of a metabolic malady
CN106771117B (zh) * 2016-11-25 2018-09-14 王婧 一种中性粒细胞抗原底片的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340977C (en) * 1988-11-15 2000-04-25 Monty Krieger Scavenger receptor protein and antibody thereto
WO1992022323A1 (en) * 1991-06-11 1992-12-23 Center For Blood Research, Inc. Intercellular adhesion molecule-3 and its binding ligands
JP3616090B2 (ja) * 1992-01-27 2005-02-02 イコス コーポレイション 細胞間接着分子関連タンパク質

Also Published As

Publication number Publication date
WO1995012666A1 (en) 1995-05-11
DE69429534T2 (de) 2002-06-27
DE69429534D1 (de) 2002-01-31
AU7940594A (en) 1995-05-23
EP1188824A3 (en) 2002-04-03
EP1188824A2 (en) 2002-03-20
EP0726942B1 (en) 2001-12-19
PT726942E (pt) 2002-06-28
DK0726942T3 (da) 2002-04-15
EP0726942A1 (en) 1996-08-21
ATE211167T1 (de) 2002-01-15
HK1042726A1 (zh) 2002-08-23
US6027922A (en) 2000-02-22

Similar Documents

Publication Publication Date Title
DE69620877T2 (de) Arzneimittelformulierungen für il-12
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
ES2099056T3 (es) Cepas de lactobacillus de origen humano, sus composiciones y usos de las mismas.
DE69309487T2 (de) Peripheralisierung hämatopoietischer stammzellen
NL300389I1 (nl) Thiofeensulfonamiden die bruikbaar zijn als carbo-anhydraseremmers.
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
ES2162614T1 (es) Composiciones formadoras de pelicula que comprenden almidones modificados e iota-carragaenina y metodo para producir capsulas blandas usando las mismas.
TR200003513T2 (tr) Pirolo[2,3d]Pirimidin kompozisyonları ve kullanımları
AU6331296A (en) Monkey monoclonal antibodies specific to human B7.1 and/or B7.2 primatized forms, pharmaceutical compositions
ATE349204T1 (de) Weichkapseln umfassend ein stärkegemisch verringerten verzweigungsgrades
ITMI950568A0 (it) Formulazioni farmaceutiche in forma di gel tissotropico
ITMI950316A0 (it) Dieteri utilizzabili nella preparazione di catalizzatori ziegler-natta
DK0783297T3 (da) Polyethylenglycol-modificerede ceramid-lipider og liposomer
FR2770767B1 (fr) Implant pour vertebre
DE69325374T2 (de) Dehnbare absorbierende struktur
BG101030A (en) Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
ES2179193T3 (es) Combinaciones sinergicas de zidovudina, 1592u89 y 3tc.
TR200200785T2 (tr) 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri
DE69231663T2 (de) Polysaccharid-protein-konjugate
FR2717081B1 (fr) Rétropeptides, anticorps dirigés contre ces derniers, et leurs utilisations pour la vaccination et le diagnostic in vitro.
ATE395363T1 (de) Monoklonale antikörper gegen das protein g3bp und deren verwendungen
ES2168314T3 (es) Anticuerpos monoclonales contra las celulas espumosas humanas y sus utilizaciones farmaceuticas y diagnosticas.
ITMI922913A1 (it) Struttura di cotile protesico, per la ricostruzione dell'acetabolo nella protesizzazione totale dell'anca.
PT948319E (pt) Celulas encapsuladas produtoras de anticorpos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 726942

Country of ref document: ES